 |
|
|
| |
Evaluation of VH3810109 (N6LS) and Cabotegravir Long-Acting, Dual-Modality Injections for HIV Treatment:
People With HIV and Staff Perspectives
|
| |
| |
20th European AIDS Conference; October 15-18, 2025; Paris, France
Cassidy A. Gutner,1 Chelsea Macfarlane,1 Viviana Wilches,2 David Dorey,3 Peter Leone,1 Paul Wannamaker,1 Jennifer N. Hill,4 Owen Cooper,5 Pavol Kral,6 Margaret Gartland,1 Christina Donatti,7 Michael Warwick-Sanders,8 Riccardo D'Agostino,8 Rulan Griesel,7 Jan Losos1
1ViiV Healthcare, Durham, NC, USA; 2GSK, Collegeville, PA, USA; 3GSK, Mississauga, Ontario, Canada; 4IQVIA, Durham, NC, USA; 5IQVIA, London, UK; 6IQVIA, Bratislava, Slovakia; 7ViiV Healthcare, London, UK; 8GSK, London, UK
|
| |
|
|
|
|
|
